» Authors » Mojtaba Noursalehi

Mojtaba Noursalehi

Explore the profile of Mojtaba Noursalehi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 170
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Shieh P, Kuntz N, Dowling J, Muller-Felber W, Bonnemann C, Seferian A, et al.
Lancet Neurol . 2023 Nov; 22(12):1125-1139. PMID: 37977713
Background: X-linked myotubular myopathy is a rare, life-threatening, congenital muscle disease observed mostly in males, which is caused by mutations in MTM1. No therapies are approved for this disease. We...
2.
Walker N, Rashid M, Yu S, Bignell H, Lumby C, Livi C, et al.
Sci Rep . 2022 Oct; 12(1):16566. PMID: 36195648
Early detection of cancer will improve survival rates. The blood biomarker 5-hydroxymethylcytosine has been shown to discriminate cancer. In a large covariate-controlled study of over two thousand individual blood samples,...
3.
Dowling J, Muller-Felber W, Smith B, Bonnemann C, Kuntz N, Muntoni F, et al.
J Neuromuscul Dis . 2022 Jun; 9(4):503-516. PMID: 35694931
Background: X-linked myotubular myopathy (XLMTM) is a life-threatening congenital myopathy that, in most cases, is characterized by profound muscle weakness, respiratory failure, need for mechanical ventilation and gastrostomy feeding, and...
4.
Duong T, Harding G, Mannix S, Abel C, Phillips D, Alfano L, et al.
J Neuromuscul Dis . 2020 Sep; 8(1):63-77. PMID: 32925083
X-linked myotubular myopathy (XLMTM) is a life-threatening, congenital myopathy characterized by extreme hypotonia, weakness, delayed motor milestones, and respiratory failure, often resulting in pediatric mortality. This study evaluated the content...
5.
Graham R, Muntoni F, Hughes I, Yum S, Kuntz N, Yang M, et al.
Arch Dis Child . 2019 Sep; 105(4):332-338. PMID: 31484632
Purpose: Individuals with X-linked myotubular myopathy (XLMTM) who survive infancy require extensive supportive care, including ventilator assistance, wheelchairs and feeding tubes. Half die before 18 months of age. We explored...
6.
Sternberg C, Petrylak D, Sartor O, Witjes J, Demkow T, Ferrero J, et al.
J Clin Oncol . 2009 Oct; 27(32):5431-8. PMID: 19805692
Purpose: This multinational, double-blind, randomized, placebo-controlled, phase III trial assessed the efficacy and tolerability of the oral platinum analog satraplatin in patients with metastatic castrate-refractory prostate cancer (CRPC) experiencing progression...